Package 16571-657-10

Brand: cevimeline hydrochloride

Generic: cevimeline hydrochloride
NDC Package

Package Facts

Identity

Package NDC 16571-657-10
Digits Only 1657165710
Product NDC 16571-657
Product ID 16571-657_640e50a9-48ba-45e3-a3cb-c14bb313cc4f
Description

100 CAPSULE in 1 BOTTLE (16571-657-10)

Marketing

Marketing Status
Marketed Since 2014-06-17
Brand cevimeline hydrochloride
Generic cevimeline hydrochloride
Sample Package No

Linked Drug Pages (1)

Cevimeline Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "640e50a9-48ba-45e3-a3cb-c14bb313cc4f", "openfda": {"upc": ["0316571657100"], "unii": ["P81Q6V85NP"], "rxcui": ["309140"], "spl_set_id": ["d4bd942a-1339-40c5-8fd4-850da5a69635"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (16571-657-10)", "package_ndc": "16571-657-10", "marketing_start_date": "20140617"}], "brand_name": "Cevimeline Hydrochloride", "product_id": "16571-657_640e50a9-48ba-45e3-a3cb-c14bb313cc4f", "dosage_form": "CAPSULE", "pharm_class": ["Cholinergic Muscarinic Agonists [MoA]", "Cholinergic Receptor Agonist [EPC]"], "product_ndc": "16571-657", "generic_name": "Cevimeline Hydrochloride", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cevimeline Hydrochloride", "active_ingredients": [{"name": "CEVIMELINE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "ANDA203775", "marketing_category": "ANDA", "marketing_start_date": "20140617", "listing_expiration_date": "20261231"}